InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Girao Tiago, Chief Financial Officer. Director active across 1 companies, notably Immunovant, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €1.3m. The latest transaction was filed on 23 April 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
US$653,04625,760 shares@ US$25.35120.012% mcap100.0% of flow
Common Stock
SEC:0001764013-26-000056·
€653,04625,760 shares@ €25.35120.012% mcap50.0% of flow
Common Stock
SEC:0001764013-26-000056:0·
2 of 2 declarations
About Girao Tiago
Tiago Girao is the Chief Financial Officer of Immunovant, Inc. He is responsible for financial management and strategy, playing a key role in the company's performance.
